Showing results (1-10 of 313) with videos related to
Sort By:
Pageof 32
Critical Reviews in Oncology/Hematology|December 26, 2006
Should intraperitoneal chemotherapy be considered as standard first-line treatment in advanced stage ovarian cancer?Patrick Petignat, Andreas du Bois, Ilan Bruchim, et al.Gynecologic Oncology|March 6, 2007
Are self-collected samples comparable to physician-collected cervical specimens for human papillomavirus DNA testing? A systematic review and meta-analysisPatrick Petignat, Daniel L Faltin, Ilan Bruchim, et al.Gynecologic and Obstetric Investigation|October 24, 2006
Long-term survival of patients with apparent early-stage (FIGO I-II) epithelial ovarian cancer: a population-based studyPatrick Petignat, Daniel de Weck, Frederic Goffin, et al.Cancer|April 12, 2005
Age-related performance of human papillomavirus testing used as an adjunct to cytology for cervical carcinoma screening in a population with a low incidence of cervical carcinomaPatrick Petignat, Daniel Faltin, Frederic Goffin, et al.Gynecologic Oncology|January 3, 2006
Salvage treatment with high-dose-rate brachytherapy for isolated vaginal endometrial cancer recurrencePatrick Petignat, Marjory Jolicoeur, Abdulaziz Alobaid, et al.Archives of Physiology and Biochemistry|June 3, 2009
The insulin-like growth factor-I receptor as an oncogeneHaim Werner, Ilan BruchimBMC Medicine|January 7, 2010
Basic and clinical significance of IGF-I-induced signatures in cancerHaim Werner, Ilan BruchimExpert Opinion on Therapeutic Targets|January 9, 2013
Targeting IGF-1 signaling pathways in gynecologic malignanciesIlan Bruchim, Haim WernerThe Lancet. Oncology|November 28, 2012
IGF-1 and BRCA1 signalling pathways in familial cancerHaim Werner, Ilan BruchimFrontiers in Endocrinology|June 7, 2014
The IGF Hormonal Network in Endometrial Cancer: Functions, Regulation, and Targeting ApproachesIlan Bruchim, Rive Sarfstein, Haim WernerPageof 32